These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 20737493

  • 1. Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.
    Yeh KY, Chang JW, Li YY, Wang CH, Wang HM.
    Head Neck; 2011 May; 33(5):734-42. PubMed ID: 20737493
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ, Kim KW.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
    [Abstract] [Full Text] [Related]

  • 3. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W, Adachi M, Zhang R, Zhou J, Zhu D.
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [Abstract] [Full Text] [Related]

  • 4. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
    Wang Y, An R, Dong X, Pan S, Duan G, Sun X.
    Urol Int; 2009 Jun; 82(2):214-21. PubMed ID: 19322013
    [Abstract] [Full Text] [Related]

  • 6. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.
    Cancer Res; 2001 Jul 15; 61(14):5432-40. PubMed ID: 11454688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes.
    Bi X, Gu J, Guo Z, Tao S, Wang Y, Tang L, Wu J, Mi Q.
    Skin Pharmacol Physiol; 2010 Jul 15; 23(2):68-78. PubMed ID: 20016248
    [Abstract] [Full Text] [Related]

  • 9. Latent membrane protein-1 of Epstein - Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell.
    Du CW, Wen BG, Li DR, Lin YC, Zheng YW, Chen L, Chen JY, Lin W, Wu MY.
    Exp Oncol; 2005 Dec 15; 27(4):267-72. PubMed ID: 16404345
    [Abstract] [Full Text] [Related]

  • 10. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
    Wu DD, Xiao YF, Geng Y, Hou J.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):90-6. PubMed ID: 20362223
    [Abstract] [Full Text] [Related]

  • 11. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
    Chen C, Zhang Y, Wang Y, Huang D, Xi Y, Qi Y.
    Anticancer Drugs; 2011 Jun 15; 22(5):435-43. PubMed ID: 21502917
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
    Shen ZY, Zhang Y, Chen JY, Chen MH, Shen J, Luo WH, Zeng Y.
    Oncol Rep; 2004 Jan 15; 11(1):155-9. PubMed ID: 14654919
    [Abstract] [Full Text] [Related]

  • 14. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Zhao XS, Song PL, Sun B, Jiang HC, Liu TF.
    Hepatobiliary Pancreat Dis Int; 2009 Oct 15; 8(5):510-7. PubMed ID: 19822495
    [Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide synergizes with everolimus (Rad001) to induce cytotoxicity of ovarian cancer cells through increased autophagy and apoptosis.
    Liu N, Tai S, Ding B, Thor RK, Bhuta S, Sun Y, Huang J.
    Endocr Relat Cancer; 2012 Oct 15; 19(5):711-23. PubMed ID: 22919067
    [Abstract] [Full Text] [Related]

  • 16. Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo.
    Wu D, Zhang Y, Huang J, Fan Z, Shi F, Wang S.
    Biochem Biophys Res Commun; 2014 Jan 10; 443(2):712-7. PubMed ID: 24333874
    [Abstract] [Full Text] [Related]

  • 17. Effect of arsenic trioxide on uveal melanoma cell proliferation in vitro.
    Wang C, Li B, Zhang H, Shi G, Li W, Jonas JB.
    Ophthalmic Res; 2007 Jan 10; 39(6):302-7. PubMed ID: 17957129
    [Abstract] [Full Text] [Related]

  • 18. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
    Wang X, Wang G, Dong D, Fu S, Yang B.
    Exp Toxicol Pathol; 2008 Sep 10; 60(6):481-8. PubMed ID: 18606528
    [Abstract] [Full Text] [Related]

  • 19. Effects of arsenic trioxide under different administration ways on T-cell lymphoma xenografts in nude mice: in vivo and in vitro experiments.
    Gao Y, Cai QQ, Li S, Bu Q, Liao H, Zhou Y, Huang HQ.
    Ai Zheng; 2009 Feb 10; 28(2):127-31. PubMed ID: 19550119
    [Abstract] [Full Text] [Related]

  • 20. The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide.
    Shen ZY, Shen J, Chen MH, Wu XY, Wu MH, Zeng Y.
    Oncol Rep; 2003 Feb 10; 10(6):1869-74. PubMed ID: 14534710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.